Over the last century, America evolved a patchwork health care system characterized by coverage gaps, high costs and uneven quality. In a new century, our challenge is to create a high-quality, low-cost health system for all. Innovation is the key. It’s time to retire an obsolete fee-for-service payment system that rewards more, not better, medical services, and replace it with strong incentives for preventive care and healthier lifestyles. We need to lower bureaucratic obstacles and encourage development of breakthrough cures, treatments and devices. Crucially, we need to equip all Americans with new, high-tech tools that enable them to monitor their own health and enhance the productivity of health-care workers.
But instead of focusing on modernizing our health care system, Washington policymakers are mired in yesterday’s ideological battles and the American people are seeing costs rise in a complex system that doesn’t always help them get the care they need. PPI’s Health Innovation Project highlights new ideas for creating a distinctively American approach to universal coverage and high-quality health care – one that is decentralized, powered by the ingenuity of our inventors, entrepreneurs and workers, and disciplined by both market competition and strong public oversight.
When it comes to health care, Americans could not face a clearer choice. Progressives believe all Americans should have access to affordable, high-quality health coverage. Republicans want to kill the Affordable Care Act – thereby depriving an additional 17 million Americans of insurance – and have no credible plan to replace it. Too often, however, […]
In searching for ways to satisfy public demand for lower drug prices, President Trump has found rare common ground with Democrats. The White House recently released a plan to reform the way pharmacy benefit managers (PBMs) negotiate prices with drugmakers on behalf of health insurance companies. Specifically, the proposal takes aim at special discounts or […]
America’s massive health care industry faces three major challenges: how to cover everyone, reduce costs, and increase productivity. Telehealth – the use of technology to help treat patients remotely – may help address all three. Telehealth reduces the need for expensive real estate and enables providers to better leverage their current medical personnel to provide […]
Dear Democratic Class of 2018, Congratulations on your election to the U.S. House of Representatives! In addition to winning your own race, you are part of something larger – the first wave of a progressive resurgence in U.S. politics. The midterm elections gave U.S. voters their first opportunity to react to the way Donald Trump […]
Republicans love to complain about “activist judges,” that is, until they find one willing to do their political bidding. On Friday, members of the GOP hailed a ruling by U.S. District Judge Reed O’Connor striking down the Affordable Care Act (ACA) as unconstitutional. They didn’t seem to care that O’Connor had to use some highly […]
New Texas ruling is the latest example of Republican efforts to kill Obamacare. But while the GOP is winning on tactics, it’s losing hearts and minds. What is the strongest political force driving America toward national health care? No, it’s not Sen. Bernie Sanders and his “Democratic Socialist” minions. It’s the Republican Party. Hang on, […]
America now depends on overseas suppliers for more than half of its medical equipment and supplies, up sharply from a few years ago. That’s based on a PPI analysis of government trade and industry data, What happened? As we go through this terrible pandemic, U.S. healthcare providers are suffering from a surprising shortage of medical […]
Is the coronavirus about to force us into the Biotech Century? Here’s a follow-up to my previous post. In response to the coronavirus pandemic, government and private researchers are taking the perhaps unprecedented step of testing the safety of a new coronavirus vaccine in volunteers before testing its safety and efficacy in animals. As one […]
Can we expect the biopharma folks to quickly find a good treatment for COVID-19? Is it time to bust up regulatory barriers holding back innovation? In March 1997, BusinessWeek magazine, now part of Bloomberg, ran a cover story entitled “The Biotech Century.” The cover language, in part, said “Thanks to fundamental advances in genetics, biology […]